Research programme: tubulin binders - Novuspharma

Drug Profile

Research programme: tubulin binders - Novuspharma

Alternative Names: Tubulin binders research programme - Novuspharma

Latest Information Update: 07 Jan 2004

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Novuspharma
  • Class
  • Mechanism of Action Tubulin polymerisation inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Colorectal cancer

Most Recent Events

  • 07 Jan 2004 Novuspharma has since merged with and into the US company Cell Therapeutics
  • 08 Sep 2003 Discontinued - Preclinical for Colorectal cancer in Italy (unspecified route)
  • 24 Oct 2001 Preclinical development for Colorectal cancer in Italy (Unknown route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top